Relationship Between Liver Cancer and Sarcopenia
The Effect of Sarcopenia on Hepatocellular Carcinoma After Hepatectomy
1 other identifier
observational
1,200
1 country
1
Brief Summary
By tracking the short-term and long-term results of patients after hepatectomy, the difference of short-term results between patients with sarcopenia and patients without sarcopenia was analyzed, and the correlation between sarcopenia and short-term and long-term results of patients after hepatectomy was explored, so as to improve people's awareness of sarcopenia and pay attention to its prevention and treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 11, 2021
CompletedFirst Submitted
Initial submission to the registry
April 9, 2022
CompletedFirst Posted
Study publicly available on registry
April 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 28, 2025
CompletedJune 15, 2022
June 1, 2022
1.3 years
April 9, 2022
June 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Short-term postoperative results
Postoperative complications;90 days readmission rate
3 months
Long-term results after operation
Overall survival; Disease free survival
10 years
Secondary Outcomes (2)
Postoperative hospitalization time
2 months
Hospitalization expenses
2 months
Interventions
The chair stand test was administered, and the time required for the patient to stand five times from a sitting position without using the arms was measured. CT scan was to scan the patient's third lumbar level. For the gait speed test, the time that patients spent walking 8 meters on a flat indoor floor at usual walking speed was measured.Grip strength test:the dominant hand and the nondominant hand were measured twice intermittently (kg), and the average value of 4 values was obtained.
Eligibility Criteria
Patients with preoperative clinical diagnosis of liver cancer admitted to the hepatobiliary surgery department and received standard tests and questionnaires.
You may qualify if:
- Patients with preoperative clinical diagnosis of liver cancer
- No cancer other than liver cancer has been diagnosed
- Age ≥18 years
You may not qualify if:
- Patients who could not complete the standard tests and questionnaires
- Patients who did not accept liver resection after evaluation of treatment plan
- Patients who had other concomitant preoperative causes of muscle weakness (injury, fracture, stroke, etc.)
- Patients who missing CT data or CT scan did not reach the level of the third lumbar vertebra (L3)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gang Chen
Wenzhou, Zhejiang, 325000, China
Biospecimen
night soil;whole blood;Tissue specimen
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gang Chen, M.D.
First Affiliated Hospital of Wenzhou Medical University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 10 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor, Principal Investigator
Study Record Dates
First Submitted
April 9, 2022
First Posted
April 21, 2022
Study Start
May 1, 2020
Primary Completion
August 11, 2021
Study Completion
August 28, 2025
Last Updated
June 15, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share